Recap: Exxon Mobil Q2 Earnings

  Exxon Mobil (NYSE:XOM) reported its Q2 earnings results on Friday, July 29, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

 

Exxon Mobil (NYSE:XOM) reported its Q2 earnings results on Friday, July 29, 2022 at 07:30 AM.

Here’s what investors need to know about the announcement.

Earnings

Exxon Mobil beat estimated earnings by 10.7%, reporting an EPS of $4.14 versus an estimate of $3.74.

Revenue was up $47.94 billion from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 2.24% drop in the share price the next day.

Here’s a look at Exxon Mobil’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 2.11 1.89 1.56 0.97
EPS Actual 2.07 2.05 1.58 1.10
Revenue Estimate 92.70B 91.28B 76.34B 65.02B
Revenue Actual 90.50B 84.97B 73.79B 67.74B

To track all earnings releases for Exxon Mobil visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

KORE Group, SeaChange International And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones settled lower by more than 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CRTD

Read More

Exelixis Announces Results From Expansion Cohort Of Phase 1b STELLAR-001 Trial Evaluating Zanzalintinib In Patients With Advanced Kidney Cancer At IKCS 2023

– Results for Exelixis' next-generation tyrosine kinase inhibitor demonstrated an objective response rate of 38% and a disease control rate of 88% – – Anti-tumor activity was observed in patients who had progressed on prior VEGFR-tyrosine kinase inhibitors, including cabozantinib –

EXEL